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b]quinolineAbstract Nitric acid was used as a highly effective oxidizing agent for the very fast oxidative aro-
matization of novel tetrahydrochromeno[4,3-b]quinoline derivatives at ambient temperature with
excellent yields.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The hantzsch 1,4-dihydropyridine reaction between 4-amino-
coumarin (Bossert et al., 1981; Nakayama and Kasoaka,
1996) and 2-benzylidene-cyclohexane-1,3-dione derivatives is
a powerful synthetic tool for constructing N-containing six-
membered heterocyclic compounds as well as in the synthesis
of natural products including chromeno[4,3-b]quinoline deriv-
atives (Cravotto et al., 2001; Simon et al., 2003; Shipman,
1994; Makioka et al., 1995; Yamanaka et al., 2000).
Chromeno[4,3-b]quinoline derivatives are found to exhibit
a wide range of biological activities (Helmchen et al., 1986;
Yamanaka et al., 2000), including psychotropic, anti-allergic,
anti-inﬂammatory and estrogenic behavior (Munoz et al.,1982; Yamada et al., 1992; Lee et al., 2004). Among them, tet-
rahydrochromeno[4,3-b]quinolines are an important class of
1,4-dihydropyridines (DHPs) and NADH models (Fig. 1).
In the human body, 1,4-dihydropyridine compounds are
oxidized to pyridine derivatives by the action of cytochrome
P-450 in the liver (Guengerich et al., 1991). The oxidation of
1,4-DHPs to the corresponding pyridine derivatives constitutes
the principal metabolic route in biological systems as well as a
facile access to the corresponding pyridine derivatives (Stout
and Meyers, 1982), which show anti-hypoxic and anti-ischemic
activities from the easily available DHPs (Khadikar and Bor-
kat, 1998; Sabitha et al., 2003). Therefore, oxidative aromati-
zation of tetrahydrochromenoquinolines has attracted
continuing interests of organic and medicinal chemists and a
plethora of protocols has been developed.
2. Result and discussion
Initially a series of novel tetrahydrochromeno[4,3-b]quinolines
were prepared via the condensation of 4-aminocoumarin and
2-Benzylidene-cyclohexane-1,3-dione derivatives under a








































































S1288 M.R. Rezaei, M. Sarvaretaherabadireported work (Miri et al., 2011), and they were used to inves-
tigate their conversion into corresponding pyridines
(Scheme 1).
Therefore a variety of 7-Aryl-9,10,11,12-tetrahydro-6H-
chromeno[4,3-b]quinoline-6,8-dione derivatives (6a-n) were
subjected to aromatization via a combination of Supported ni-
tric acid on silica gel in chloroform at room temperature with
excellent yields (Scheme 2).
Also the above reaction was experienced using other cata-
lysts such as CrO3 (Grinsteins et al., 1967), MnO2 (VandenEynde et al., 1995) ferric nitrate (Khadikar and Borkat,
1998; Sadeghi et al., 2001; Vanden Eynde and Mayence,
2003) nicotinium dichromate (Sadeghi et al., 2000) and Mul-
ti-wall carbon nanotubes modiﬁed with manganese complex
(MWNTs) but the yields were unsatisfactory (Siswana et al.,
2008). This reported oxidation procedure is very simple, efﬁ-
cient and heterogeneous for the oxidative aromatization of no-
vel tetrahydrochromeno[4,3-b]quinoline derivatives using
supported nitric acid on silica gel in a short reaction time at





































Table 1 Oxidative aromatization of novel tetrahydrochromeno[4,3-b]quinolines with SiO2–HNO3 in
chloroform at room temperature.
Grop G Substrate Product Time (min) MP (C) Yield (%)a
o-CH3 6a 7a Immed 210–212 94
m-CH3 6b 7b Immed 172–174 95
p-CH3 6c 7c Immed 241–243 98
o-OCH3 6d 7d Immed 180–182 93
m-OCH3 6e 7e Immed 155–157 94
p-OCH3 6f 7f Immed 185–187 97
o-Cl 6g 7g Immed 253–255 96
m-Cl 6h 7h Immed 188–190 97
p-Cl 6i 7i Immed 281–283 98
m-NO2 6j 7j Immed 161–163 95
p-NO2 6k 7k Immed 265–267 97
m-Br 6l 7l Immed 184–186 96
p-Br 6m 7m Immed 279–281 97
H 6n 7n Immed 121–123 98
a Isolated yield.
A convenient method for the oxidative aromatization of novel tetrahydrochromeno[4,3-b]quinolines with nitric acid S1289reaction media by simple ﬁltration and evaporation of CHCl3.
It is interesting to note that no side reaction such as nitration
of tetrahydrochromenoquinolines including activation of an
aromatic moiety was observed in this investigation (Table 1).
In summary in this paper we have introduced another abil-
ity of SiO2–HNO3 as an efﬁcient oxidizing agent for the oxida-
tion of tetrahydrochromeno[4,3-b]quinolines under mild and
heterogeneous conditions. Also the cheapness and availability
of the reagent, easy and clean work-up and excellent yields
make this method attractive for chemists.3. Experimental
3.1. Materials and apparatus
Chemicals and all solvents used in this study were purchased
from Merck AG and Aldrich Chemical. Melting points were
determined on a Koﬂer hot stage apparatus and are uncor-
rected. The IR spectra were obtained on a Shimatdzu 470 spec-
trophotometer (potassium bromide disks).1H NMR spectra
were measured using a Bruker FT-500 spectrometer, and
chemical shifts are expressed as d (ppm) with tetramethylsilane
as internal standard. The mass spectra were run on a Finnigan
TSQ-70 spectrometer at 70 eV. Merck silica gel 60 F254 plates
were used for analytical TLC; column chromatography was
performed on Merck silica gel (70–230 mesh). Yields are puri-
ﬁed products and were not optimized.3.2. Typical procedure for the oxidative aromatization of 7-aryl-
9,10,11,12-tetrahydro-6H-chromeno[4,3-b]quinoline-6,8-dione
derivatives
To a solution of compound 6 (5.4 mmol) in CHCl3 (5 mL),
SiO2–HNO3 (0.6 g) was added. Reaction mixture was stirred
at room temperature for 2 min (the reaction progress was mon-
itored by TLC) and then ﬁltered. Finally the ﬁltrate was evap-
orated to dryness under reduced pressure, and the crude
product was puriﬁed by short column chromatography and
product 7 was obtained in excellent yield.
3.3. Characteristic data of new compounds
3.3.1. 7-(2-Methylphenyl)-10,11-dihydro-6H-chromeno[4,3-
b]quinoline-6,8-dione (7a)
Yield = 94%, Mp = 210–212 C.
IR (KBr) m: 2922, 2848 (C–H aliphatic), 1754 (C‚O ester),
1691 (C‚O ketone), 757 (C–H oop) cm1.
1H NMR (CDCl3, 500MHz), d (ppm): 2.02 (s, 3H, CH3), 2.24
(m, 2H, J=6.6 Hz, H10), 2.66 (t, 2H, J=6.6 Hz, H9), 3.38 (t,
2H, J=6.6 Hz, H11), 6.81 (d, 1H, J=7.0 Hz, H15), 7.23 (t,
1H, J=7.0 Hz H17), 7.28–7.35 (m, 3H, H16, H18, H4), 7.40 (t,
1H, J=8.0 Hz, H2), 7.61 (t, 1H, J=8.0 Hz, H3), 8.68 (d, 1H,
J=8.0 Hz, H1).
13C NMR (CDCl3-d), d: 20.01, 20.98, 34.61, 40.13, 115.13,
116.90, 118.83, 124.61, 124.89, 125.58, 126.09, 127.44, 127.69,
S1290 M.R. Rezaei, M. Sarvaretaherabadi129.26, 133.33, 134.24, 137.84, 153.43, 154.13, 156.39, 157.92,
169.58, 196.14.
MS: m/z (%), 355 (M+, 44), 340 (44), 327 (37), 299 (100),
271 (37), 151 (50), 126 (50), 114 (63), 100 (44), 87 (25).
3.3.2. 7-(3-Methylphenyl)-10,11-dihydro-6H-chromeno[4,3-
b]quinoline-6,8-dione (7b)
Yield = 95%, Mp = 172–174 C.
IR (KBr) m: 2848 (C–H aliphatic), 1754 (C‚O ester), 1691
(C‚O ketone), 757 (C–H oop) cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.24 (m, 2H,
J= 6.6 Hz, H10), 2.39 (s, 3H, CH3), 2.67 (t, 2H, J= 6.5 Hz,
H9), 3.36 (t, 2H, J= 6.5 Hz, H11), 6.91 (m, 2H, H14, H16),
7.24 (d, 1H, J= 7.5 Hz, H18), 7.30 (d, 1H, J= 8.0 Hz, H4),
7.33 (t, 1H, J= 7.5 Hz, H17), 7.39 (t, 1H, J= 8.0 Hz, H2),
7.60 (t, 1H, J= 8.0 Hz, H3), 8.67 (d, 1H, J= 8.0 Hz, H1).
13CNMR(CDCl3-d),d: 20.93,21.64,34.56,40.33,115.08,116.83,
118.80, 123.34, 124.56, 125.67, 126.11, 126.78, 127.74, 128.41, 133.25,
133.40, 137.35, 153.41, 153.86, 156.60, 158.13, 169.29, 196.39.
MS: m/z (%), 355 (M+, 48), 340 (38), 265 (38), 149 (86),
121 (100), 105 (23), 92 (35), 71 (35), 57 (42), 43 (50).
3.3.3. 7-(4-Methylphenyl)-10,11-dihydro-6H-chromeno[4,3-
b]quinoline-6,8-dione (7c)
Yield = 98%, Mp = 241–243 C.
IR (KBr) m: 3033 (C–H aromatic), 2853 (C–H aliphatic),
1750(C‚O ester), 1698 (C‚O ketone), 759 (C–H oop) cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.24 (m, 2H,
J= 6.6 Hz, H10), 2.46 (s, 3H, CH3), 2.68 (t, 2H, J= 6.6 Hz,
H9), 3.37 (t, 2H, J= 6.3 Hz, H11), 7.02 (d, 2H, J= 8.0 Hz,
H15, H17), 7.27 (d, 1H, J= 8.0 Hz, H14, H18), 7.32 (d, 1H,
J= 8.2 Hz, H4), 7.41 (t, 1H, J= 8.2 Hz, H2), 7.61 (t, 1H,
J= 8.2 Hz, H3), 8.68 (d, 1H, J= 8.2 Hz, H1).
13C NMR (CDCl3-d), d: 20.94, 21.57, 34.54, 40.33, 115.19,
116.86, 118.84, 124.56, 126, 11, 126.15, 127.94, 128.75, 133.24,
134.93, 137.19, 153.42, 153.89, 156.67, 158.25, 169.27, 196.58.




Yield = 93%, Mp = 180–182 C.
IR (KBr) m: 3056(C–H aromatic), 2852(C–H aliphatic),
1749(C‚O ester), 1693(C‚O ketone), 753(C–H oop) cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.25 (m, 2H,
J= 6.7 Hz, H10), 2.69 (t, 2H, J= 6.7 Hz, H9), 3.38 (t, 2H,
J= 6.7 Hz, H11), 3.74 (s, 3H, OMe), 6.90 (d, 1H,
J= 6.0 Hz, H15), 6.89 (d, 1H, J= 6.0 Hz, H18), 7.00 (m,
1H, J= 6.0 Hz, H17), 7.31 (d, 1H, J= 8.2 Hz, H4), 7.41 (t,
1H, J= 6.0 Hz, H16), 7.43 (t, 1H, J= 8.2 Hz, H2), 7.61 (t,
1H, J= 8.2 Hz, H3), 8.68 (d, 1H, J= 8.2 Hz, H1).
13C NMR (CDCl3-d), d: 20.97, 34.48, 40.06, 55.67, 110.39,
115.60, 116.82, 118.97, 120.73, 124.49, 126.04, 126.76, 127.40,
128.07, 129.21, 133.08, 153.32, 153.51, 153.87, 155.85, 158.13,
169.18, 196.28.




Yield = 94%, Mp = 155–157 C.IR (KBr) m: 3060(C–H aromatic), 2835(C–H aliphatic),
1755(C‚O ester), 1692(C‚O ketone), 766(C–H oop) cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.25 (m, 2H,
J= 6.5 Hz, H10), 2.68 (t, 2H, J= 6.5 Hz, H9), 3.37 (t, 2H,
J= 6.5 Hz, H11), 3.82 (s, 3H, OMe), 6.67 (s, 1H, H14), 6.72
(d, 1H, J= 7.5 Hz,H18), 6.98 (d, 1H, J= 7.5 Hz, H
16), 7.31
(d, 1H, J= 8.0 Hz, H4), 7.37–7.42(m, 2H, H17,H2), 7.61 (t,
1H, J= 8.0 Hz, H3), 8.68 (d, 1H, J= 8.0 Hz, H1).
13C NMR (CDCl3-d), d: 20.91, 34.56, 40.29, 55.13, 112.49,
112.56, 115.02, 116.86, 118.76, 124.57, 126.11, 127.62, 128.97,
133.29, 133.89, 139.26, 153.41, 153.91, 155.96, 157.97, 159.33,
169.35, 196.17.
MS: m/z (%), 371 (M+, 44), 340(37), 341 (50), 196 (63), 120
(38), 91 (100), 43 (50).
3.3.6. 7-(4-Methoxyphenyl)-10,11-dihydro-6H-chromeno[4,3-
b]quinoline-6,8-dione(7f)
Yield = 97%, Mp = 185–187 C.
IR (KBr) m: 2854 (C–H aliphatic), 1747 (C‚O ester), 1688
(C‚O ketone), 761 (C–H oop) cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.24 (m, 2H,
J= 6.6 Hz H10), 2.69 (t, 2H, J= 6.5 Hz, H9), 3.37 (t, 2H,
J= 6.4 Hz, H11), 3.88 (s, 3H, OMe), 7.00 (d, 2H,
J= 8.7 Hz, H15,H17), 7.05 (d, 1H, J= 8.7 Hz, H14,H18),
7.32 (d, 1H, J= 8.2 Hz, H4), 7.41(t, 1H, J= 8.2 Hz, H2),
7.62(t, 1H, J= 8.2 Hz, H3), 8.68 (d, 1H, J= 8.2 Hz, H1).
13C NMR (CDCl3-d), d: 20.94, 34.54, 40.38, 55.11, 113.51,
115.29, 116.84, 118.85, 124.56, 126.12, 127.73, 128.11, 129.89,
130.03, 133.23, 153.40, 153.89, 156.37, 158.33, 169.25, 196.70.
MS: m/z (%), 371 (M+, 11), 289 (18), 149 (29), 121 (32), 85
(63), 71 (88), 57 (100), 43 (95).
3.3.7. 7-(2-Cholorophenyl)-10,11-dihydro-6H-chromeno[4,3-
b]quinoline-6,8-dione (7g)
Yield = 96%, Mp = 253–255 C.
IR (KBr) m: 3068 (C–H aromatic), 2854 (C–H aliphatic),
1744 (C‚O ester), 1690 (C‚O ketone), 762 (C–H oop) cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.27 (m, 2H,
J= 6.5 Hz, H10), 2.69 (t, 2H, J= 6.5 Hz, H9), 3.41 (t, 2H,
J= 6.5 Hz, H11), 7.03 (d, 1H, J= 7.8 Hz, H18), 7.27–7.43
(m, 4H, H2, H4, H16, H17), 7.50 (d, 1H, J= 7.8 Hz, H15),
7.62 (t, 1H, J= 7.8 Hz, H3), 8.70 (d, 1H, J= 7.8 Hz, H1).
13C NMR (CDCl3-d), d: 20.88, 34.55, 39.89, 114.97, 116.94,
118.75, 124.68, 126.08, 126.68, 127.09, 127.18, 128.92, 130.77,
133.42, 133.90, 137.28, 152.92, 153.38, 154.26, 157.99, 169.69,
196.94.
MS: m/z (%), 377 (M++2, 33), 375 (M+, 100), 340 (25),
187 (13), 127 (13), 113 (13), 100 (10), 87 (5).
3.3.8. 7-(3-Cholorophenyl)-10,11-dihydro-6H-chromeno[4,3-
b]quinoline-6,8-dione (7h)
Yield = 97%, Mp = 188–190 C.
IR (KBr) m: 3018 (C–H aromatic), 2853 (C–H aliphatic),
1744 (C‚O ester), 1691 (C‚O ketone), 757 (C–H oop bend-
ing) cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.23–2.28 (m, 2H,
J= 6.5 Hz, H10), 2.67–2.70 (t, 2H, J= 6.5 Hz, H9), 3.39–
3.40 (t, 2H, J= 6.5 Hz, H11), 7.02 (d, 1H, J= 7.0 Hz, H16),
7.10 (s, 1H, H14), 7.30 (d, 1H, J= 8.0 Hz, H4), 7.37–7.42
(m, 3H, H2, H17, H18), 7.62 (t, 1H, J= 8.0 Hz, H3), 8.68 (d,
1H, J= 8.0 Hz, H1).
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Yield = 98%, Mp = 281–283 C.
IR (KBr) m: 2851 (C–H aliphatic), 1745 (C‚O ester), 1691
(C‚O ketone), 753 (C–H oop) cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.25 (m, 2H,
J= 6.6 Hz H10), 2.68 (t, 2H, J= 6.6 Hz, H9), 3.38 (t, 2H,
J= 6.6 Hz, H11), 7.05 (d, 1H, J= 8.3 Hz, H14, H18), 7.33
(d, 1H, J= 8.2 Hz, H4), 7.41 (d, 1H, J= 8.2 Hz, H2), 7.43
(d, 1H, J= 8.3 Hz, H15, H17),7.62(t, 1H, J= 8.2 Hz, H3),
8.68 (d, 1H, J= 8.2 Hz, H1).
13C NMR (CDCl3-d), d: 20.87, 34.56, 40.28, 114.85, 116.90,
118.62, 124.70, 126.16, 126.25, 127.64, 128.29, 133.47, 133.88,
136.46, 153.39, 154.07, 155.15, 158.08, 169.55, 196.34.
MS: m/z (%), 377 (M++2, 10), 375 (M+, 29), 289 (100),
265 (58), 237 (64), 121 (100), 85 (44), 71 (59), 57 (80).
3.3.10. 7-(3-Nitrophenyl)-10,11-dihydro-6H-chromeno[4,3-
b]quinoline-6,8-dione (7j)
Yield = 95%, Mp = 161–163 C.
IR (KBr) m: 3086 (C–H aromatic), 2849 (C–H aliphatic),
1748 (C‚O ester), 1693 (C‚O ketone), 1543, 1343 (N‚O ni-
tro aryl), 765 (C–H oop) cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.28 (m, 2H,
J= 6.6 Hz H10), 2.68 (t, 2H, J= 6.6 Hz, H9), 3.39 (t, 2H,
J= 6.6 Hz, H11), 7.33 (d, 1H, J= 8.0 Hz, H4), 7.42–7.48
(m, 2H, H2, H17), 7.61–7.66 (m, 2H, H3, H18), 7.98 (s, 1H,
H14), 8.31 (d, 1H, J= 7.75 Hz, H16), 8.70 (d, 1H,
J= 8.0 Hz, H1).
13C NMR (CDCl3-d), d: 20.78, 34.58, 40.16, 114.75, 116.94,
118.51, 123.21, 123.47, 124.94, 125.40, 126.25, 126.93, 128.82,
132.68, 133.77, 139.90, 148.09, 153.30, 154.34, 158.38, 170.06,
196.26.
MS: m/z (%), 386 (M+, 30), 289 (37), 167 (62.5), 149 (51),
121 (29), 77 (98), 43 (100).
3.3.11. 17-(4-Nitrophenyl)-10,11-dihydro-6H-chromeno[4,3-
b]quinoline-6,8-dione (7k)
Yield = 97%, Mp = 265–267 C.
IR (KBr) m: 3072 (C–H aromatic), 2951, 2849(C–H ali-
phatic), 1741 (‚O ester), 1689 (C‚O ketone), 1547, 1346
(N‚O nitro aryl), 765 (C–H oop) cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.25 (m, 2H,
J= 6.4 Hz, H10), 2.68 (t, 2H, J= 6.4 Hz, H9), 3.39 (t, 2H,
J= 6.4 Hz, H11), 7.30 (d, 1H, J= 8.6 Hz, H14, H18), 7.33
(d, 1H, J= 8.2 Hz, H4), 7.43 (t, 1H, J= 8.0 Hz, H2), 7.64
(t, 1H, J= 8.0 Hz, H3), 8.31 (d, 1H, J= 8.6 Hz, H15, H17),
8.70 (d, 1H, J= 8.0 Hz, H1).
13C NMR (CDCl3-d), d: 20.79, 34.58, 40.12, 114.54, 116.98,
118.49, 123.44, 124.96, 126.26, 126.66, 127.15, 133.82, 145.80,
147.17, 153.35, 153.83, 154.35, 158.30, 170.04, 196.15.
MS: m/z (%), 386 (M+, 12.5), 289 (34), 265 (18), 121 (80),
84 (100), 57 (75).3.3.12. 7-(3-Bromophenyl)-10,11-dihydro-6H-chromeno[4,3-
b]quinoline-6,8-dione (7l)
Yield = 96%, Mp = 184–186 C.
IR (KBr) m: 3070(C–H aromatic), 2954 (C–H aliphatic),
1748 (C‚O ester), 1693 (C‚O ketone), 768 (C–H oop) cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.25 (m, 2H,
J= 6.5 Hz, H10), 2.69 (t, 2H, J= 6.5 Hz, H9), 3.39 (t, 2H,
J= 6.5 Hz, H11), 7.08 (d, 1H, J= 7.6 Hz, H16), 7.24 (s, 2H,
H14), 7.32, 7.35 (m, 2H, H4, H17), 7.41 (t, 1H, J= 8.0 Hz,
H2), 7.58 (d, 1H, J= 7.6 Hz, H18), 7.64 (t, 1H, J= 8.0 Hz,
H3), 8.68 (d, 1H, J= 8.0 Hz, H1).
13C NMR (CDCl3-d), d: 20.85, 34.58, 40.24, 114.88, 116.91,
118.64, 122.04, 124.71, 125.03, 126.16, 127.22, 128.96, 129.38,
130.52, 133.50, 140.01, 153.40, 154.08, 154.40, 158.08, 169.61,
196.06.
MS: m/z (%), 421 (M++2, 98), 419 (100), 340 (33), 312
(68), 169 (80), 155 (38), 127 (67), 113 (70), 100 (60), 87 (47).
3.3.13. 7-(4-Bromophenyl)-10,11-dihydro-6H-chromeno[4,3-
b]quinoline-6,8-dione (7m)
Yield = 97%, Mp = 279–281 C.
IR (KBr) m: 3042 (C–H aromatic), 2922 (C–H aliphatic),
1745 (C‚O ester), 1693 (C‚O ketone), 771(C–H oop) cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.24 (m, 2H,
J= 6.5 Hz, H10), 2.67 (t, 2H, J= 6.5 Hz, H9), 3.38 (t, 2H,
J= 6.4 Hz, H11), 6.98 (d, 1H, J= 8.3 Hz, H14, H18), 7.32
(d, 1H, J= 7.0 Hz, H4), 7.40 (t, 1H, J= 7.0 Hz, H2), 7.58
(d, 1H, J= 8.3 Hz, H15, H17), 7.62 (t, 1H, J= 70 Hz, H3),
8.67 (d, 1H, J= 7.0 Hz, H1).
13C NMR (CDCl3-d), d: 20.87, 34.56, 40.28, 114.92, 116.91,
118.68, 124.71, 126.16, 126.26, 127.40, 127.91, 131.19, 133.48,
136.99, 153.39, 154.08, 155.10, 158.23, 169.57, 196.34.
MS: m/z (%), 421 (M++2, 11), 419 (M+, 11), 330 (13), 289
(100), 216 (22), 149 (20), 83 (31), 57 (76).
3.3.14. 7-(Phenyl)-10,11-dihydro-6H-chromeno[4,3-
b]quinoline-6,8-dione (7n)
Yield = 98%, Mp = 121–123 C.
IR (KBr) m: 3056 (C–H aromatic), 2949 (C–H aliphatic),
1744 (C‚O ester), 1693 (C‚O ketone), 776 (C–H oop) cm1.
1H NMR (CDCl3, 500 MHz), d (ppm): 2.25 (m, 2H,
J= 6.6 Hz, H10), 2.68 (t, 2H, J= 6.6 Hz, H9), 3.38 (t, 2H,
J= 6.6 Hz, H11), 7.13 (m, 2H, H14, H18), 7.32 (d, 1H,
J= 8.0 Hz, H4), 7.42 (t, 1H, J= 8.0 Hz, H2), 7.46 (m, 3H,
H15, H16, H17), 7.61 (t, 1H, J= 8.0 Hz, H3), 8.68 (d, 1H,
J= 8.0 Hz, H1).
13C NMR (CDCl3-d), d: 20.91, 34.57, 40.30, 115.06, 116.87,
118.80, 124.59, 124.75, 126.13, 126.16, 127.56, 127.92, 133.30,
138, 153.43, 153.95, 156.38, 158.19, 169.38, 196.36.
MS: m/z (%), 341 (M+, 81), 313 (69), 289 (38), 196 (44),
120 (75), 90 (100), 76 (44).References
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